IDRI Awarded Grant from Bill and Melinda Gates Foundation to Identify Candidates for Novel TB Drugs

January 14th, 2011|Press Releases|

Seattle, WA | January 14, 2011 The Infectious Disease Research Institute (IDRI) today announced it has received a multi-million dollar grant from the Bill and Melinda Gates Foundation for "Chemical genomics for the identification of targets and leads in [...]

IDRI Receives DARPA Grant to Develop a Novel Vaccine to Combat Pandemic Flu

January 7th, 2011|Press Releases|

Seattle, WA | January 7, 2011 The Infectious Disease Research Institute (IDRI) today announced it has received a multi-million dollar grant from the Defense Advanced Research Projects Agency (DARPA), and the Army Research Office (ARO), both parts of United [...]

IDRI Awarded $790,200 Grant from US Government to Develop Pandemic Flu Vaccine With Cantacuzino Institute

December 3rd, 2010|Press Releases|

Seattle, WA | December 3, 2010 The Infectious Disease Research Institute (IDRI) today announced it has received a $790,200 grant from the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services. [...]

IDRI Awarded Contract from BARDA to Develop Next Generation Adjuvants for Pandemic Influenza

December 3rd, 2010|Press Releases|

Seattle, WA | December 3, 2010 The Infectious Disease Research Institute (IDRI) has been awarded an $1.8 million contract from the Biomedical Advance Research and Development Authority (BARDA). IDRIʼs work will focus on development of adjuvant formulations with options [...]

IDRI Develops Novel Tuberculosis Vaccine, New Study in Science Reports

October 14th, 2010|Press Releases|

Seattle, WA | October 14, 2010 The Infectious Disease Research Institute (IDRI) announces it has developed a new tuberculosis (TB) vaccine that protects against TB including drug-resistant strains of the disease in animal studies. The results of these studies [...]

IDRI and Merial Enter into Research Collaboration

July 14th, 2010|Press Releases|

Seattle, WA | July 14, 2010 Global animal health company Merial Ltd. and non-profit biotechnology organization the Infectious Disease Research Institute (IDRI) today announce they have agreed to cooperate regarding the research and development of certain vaccines for animals. [...]

The Lilly TB Drug Discovery Initiative Announces New Collaborator

November 29th, 2009|Press Releases|

Seattle, WA | November 29, 2009 On behalf of The Lilly TB Drug Discovery Initiative, the Infectious Disease Research Institute (IDRI) today signed a Memorandum of Understanding (MOU) with Academia Sinica, a research institution based in Taiwan, to collaborate [...]

IDRI Initiates Therapeutic Vaccine Clinical Trial in Sudan Against Leishmaniasis

August 27th, 2009|Press Releases|

Seattle, WA | August 27, 2009 IDRI (Infectious Disease Research Institute) announced today the start of a clinical trial in Sudan to test its leishmaniasis vaccine candidate for the treatment of post kala-azar dermal leishmaniasis (PKDL), a complication of [...]

IDRI Awarded $314,500 Grant From Murdock Trust to Expand TB Drug Discovery Program

June 25th, 2009|Press Releases|

Seattle, WA | June 25, 2009 The Infectious Disease Research Institute today announced it has received a $314,500 grant from the M.J. Murdock Charitable Trust. This new funding will support IDRI's efforts to better understand the mechanisms of tuberculosis [...]

IDRI Makes its Adjuvant Available to Increase Global Supply of Pandemic Vaccines

June 11th, 2009|Press Releases|

Seattle, WA | June 11, 2009 Adjuvants are a major component of a global strategy against the newly declared swine flu pandemic Following the World Health Organization (WHO) declaration of swine flu pandemic, the Infectious Disease Research Institute (IDRI) [...]

Load More